| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Scientific Officer | Chief Scientific Officer
1 company
Steven L. Krill last filed a Form 4 in January 2018, as EVP & Chief Scientific Officer at EGRX. Steven L. Krill's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,000 shares of EGRX. The EGRX filings lean toward selling, a net 90,597 shares.
Steven L. Krill has 9 Form 4 filings on record from March 2015 to January 2018, all as EVP & Chief Scientific Officer at Eagle Pharmaceuticals (EGRX), 2015–2018.
The 46 reported transactions were 21 option exercises, 19 open-market sales, 5 option or other derivative awards and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $7.0M.
The largest open-market sale was 50,505 shares of EGRX at an average $76.40 on December 23, 2016, about $3.9M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | EGRX Eagle Pharmaceuticals, Inc. | EVP & Chief Scientific Officer | Sale+OE | 14,125 | $81.07 | $1,145,130.19 | - | |
| Dec 23, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP & Chief Scientific Officer | Sale+OE | 50,505 | $76.40 | $3,858,621.81 | - | |
| Dec 13, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP & Chief Scientific Officer | Sale+OE | 10,000 | $73.62 | $736,163.00 | - | |
| Nov 30, 2016 | EGRX Eagle Pharmaceuticals, Inc. | EVP & Chief Scientific Officer | Sale+OE | 5,987 | $80.00 | $478,960.00 | - | |
| Jun 16, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 9,980 | $81.60 | $814,368.00 | - |